Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(2.06)
# 1,514
Out of 4,666 analysts
380
Total ratings
32.67%
Success rate
-3.68%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Reiterates: Buy | $27 | $12.78 | +111.27% | 5 | Nov 15, 2024 | |
| PGEN Precigen | Reiterates: Buy | $4 | $0.84 | +378.07% | 8 | Nov 15, 2024 | |
| IPHA Innate Pharma | Reiterates: Buy | $12 | $1.69 | +582.29% | 11 | Nov 15, 2024 | |
| ITOS iTeos Therapeutics | Reiterates: Buy | $46 | $7.85 | +485.99% | 8 | Nov 15, 2024 | |
| LPTX Leap Therapeutics | Reiterates: Buy | $5.5 | $2.59 | +112.36% | 12 | Nov 15, 2024 | |
| AFMD Affimed | Reiterates: Buy | $10 | $2.72 | +267.65% | 11 | Nov 15, 2024 | |
| POAI Predictive Oncology | Downgrades: Neutral | n/a | $0.65 | - | 2 | Nov 15, 2024 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $5 → $1.5 | $0.34 | +340.66% | 12 | Nov 14, 2024 | |
| OCGN Ocugen | Reiterates: Buy | $7 | $0.92 | +662.11% | 17 | Nov 14, 2024 | |
| ABSI Absci | Reiterates: Buy | $7 | $2.68 | +161.19% | 9 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.32 | +2,388.34% | 12 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $10.43 | +5.47% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.39 | +187.77% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $20.77 | +92.59% | 4 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $9.63 | +128.45% | 10 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.79 | +2,101.81% | 9 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $57.26 | +4.79% | 16 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $63 | $48.96 | +28.68% | 10 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.40 | +900.00% | 9 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $20.36 | +170.14% | 15 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $56.09 | +42.63% | 17 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.95 | +69.49% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $0.72 | +1,151.74% | 12 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $16.78 | +66.87% | 15 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.39 | +2,232.21% | 7 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.45 | +675.51% | 13 | Aug 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $3 → $0.95 | $0.71 | +34.03% | 4 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $4.23 | +160.05% | 10 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7.5 → $9 | $3.46 | +160.12% | 10 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.82 | +83.25% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $13 | $1.85 | +602.70% | 4 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.21 | +1,966.12% | 11 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.06 | +230.19% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.58 | +932.52% | 5 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $9.06 | +21.41% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.45 | +479.71% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.75 | +562.95% | 5 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $9.94 | +50.91% | 11 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $4.96 | +81.45% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.13 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.33 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.52 | +492.11% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $2.94 | +750.34% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.72 | +451.47% | 1 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.09 | +139.23% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.56 | +156.41% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $5.26 | +128.14% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $1.48 | +1,251.35% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $16.14 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $80 | $2.72 | +2,841.18% | 5 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $8.24 | -27.18% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $4.56 | +228.95% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $3.79 | +770.71% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $9.93 | -4.33% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $6.40 | +218,650.00% | 1 | Mar 5, 2020 |
Celcuity
Nov 15, 2024
Reiterates: Buy
Price Target: $27
Current: $12.78
Upside: +111.27%
Precigen
Nov 15, 2024
Reiterates: Buy
Price Target: $4
Current: $0.84
Upside: +378.07%
Innate Pharma
Nov 15, 2024
Reiterates: Buy
Price Target: $12
Current: $1.69
Upside: +582.29%
iTeos Therapeutics
Nov 15, 2024
Reiterates: Buy
Price Target: $46
Current: $7.85
Upside: +485.99%
Leap Therapeutics
Nov 15, 2024
Reiterates: Buy
Price Target: $5.5
Current: $2.59
Upside: +112.36%
Affimed
Nov 15, 2024
Reiterates: Buy
Price Target: $10
Current: $2.72
Upside: +267.65%
Predictive Oncology
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.65
Upside: -
X4 Pharmaceuticals
Nov 14, 2024
Maintains: Buy
Price Target: $5 → $1.5
Current: $0.34
Upside: +340.66%
Ocugen
Nov 14, 2024
Reiterates: Buy
Price Target: $7
Current: $0.92
Upside: +662.11%
Absci
Nov 13, 2024
Reiterates: Buy
Price Target: $7
Current: $2.68
Upside: +161.19%
Nov 13, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.32
Upside: +2,388.34%
Nov 13, 2024
Reiterates: Buy
Price Target: $11
Current: $10.43
Upside: +5.47%
Nov 13, 2024
Reiterates: Buy
Price Target: $4
Current: $1.39
Upside: +187.77%
Nov 11, 2024
Reiterates: Buy
Price Target: $40
Current: $20.77
Upside: +92.59%
Nov 11, 2024
Reiterates: Buy
Price Target: $22
Current: $9.63
Upside: +128.45%
Nov 8, 2024
Reiterates: Buy
Price Target: $18
Current: $0.79
Upside: +2,101.81%
Nov 8, 2024
Reiterates: Buy
Price Target: $60
Current: $57.26
Upside: +4.79%
Nov 7, 2024
Reiterates: Buy
Price Target: $63
Current: $48.96
Upside: +28.68%
Nov 1, 2024
Reiterates: Buy
Price Target: $14
Current: $1.40
Upside: +900.00%
Nov 1, 2024
Reiterates: Buy
Price Target: $55
Current: $20.36
Upside: +170.14%
Oct 31, 2024
Reiterates: Buy
Price Target: $80
Current: $56.09
Upside: +42.63%
Oct 31, 2024
Initiates: Buy
Price Target: $5
Current: $2.95
Upside: +69.49%
Oct 29, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $0.72
Upside: +1,151.74%
Oct 11, 2024
Reiterates: Buy
Price Target: $28
Current: $16.78
Upside: +66.87%
Sep 17, 2024
Reiterates: Buy
Price Target: $9
Current: $0.39
Upside: +2,232.21%
Aug 29, 2024
Reiterates: Buy
Price Target: $19
Current: $2.45
Upside: +675.51%
Aug 23, 2024
Downgrades: Neutral
Price Target: $3 → $0.95
Current: $0.71
Upside: +34.03%
Aug 21, 2024
Reiterates: Buy
Price Target: $11
Current: $4.23
Upside: +160.05%
Aug 19, 2024
Maintains: Buy
Price Target: $7.5 → $9
Current: $3.46
Upside: +160.12%
Aug 16, 2024
Reiterates: Buy
Price Target: $7
Current: $3.82
Upside: +83.25%
Aug 16, 2024
Maintains: Buy
Price Target: $9 → $13
Current: $1.85
Upside: +602.70%
Aug 13, 2024
Reiterates: Buy
Price Target: $25
Current: $1.21
Upside: +1,966.12%
Aug 13, 2024
Reiterates: Buy
Price Target: $3.5
Current: $1.06
Upside: +230.19%
Aug 7, 2024
Reiterates: Buy
Price Target: $6
Current: $0.58
Upside: +932.52%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $9.06
Upside: +21.41%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $3.45
Upside: +479.71%
Mar 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.75
Upside: +562.95%
Mar 14, 2024
Reiterates: Buy
Price Target: $15
Current: $9.94
Upside: +50.91%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $4.96
Upside: +81.45%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.13
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $4.33
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.52
Upside: +492.11%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $2.94
Upside: +750.34%
Jan 4, 2023
Initiates: Buy
Price Target: $15
Current: $2.72
Upside: +451.47%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $2.09
Upside: +139.23%
Nov 4, 2022
Maintains: Buy
Price Target: $3 → $4
Current: $1.56
Upside: +156.41%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $5.26
Upside: +128.14%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $1.48
Upside: +1,251.35%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $16.14
Upside: -
Feb 17, 2022
Maintains: Buy
Price Target: $150 → $80
Current: $2.72
Upside: +2,841.18%
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $8.24
Upside: -27.18%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $4.56
Upside: +228.95%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $3.79
Upside: +770.71%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $9.93
Upside: -4.33%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $6.40
Upside: +218,650.00%